There is increased risk for cardiotoxicity among Black and Hispanic patients who receive anthracycline chemotherapy for treatment of cancer.

A study was conducted to examine the prognostic value of invasive and noninvasive assessment in athletes with complex ventricular arrhythmias.

The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

For patients with metabolic dysfunction-associated steatohepatitis and fibrosis, semaglutide is associated with improved liver histologic outcomes.

For patients with carotid stenosis ≥50% with a low/intermediate predicted stroke risk, there is no benefit for revascularization added to OMT.

Despite widespread vaccine availability and improved treatment strategies, certain patients with SARDs remain highly vulnerable to severe COVID-19 outcomes.

The MACE risk associated with initiating ustekinumab is comparable to that of adalimumab, etanercept, and secukinumab in patients with PsO or PsA.

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

A discussion about screening for Lp(a), a factor that can contribute to hypertension, with Wenjun Fan, MD, PhD, and Arya Aminorroaya, MD, MPH.

A scientific statement has been published by the ACC and Heart Rhythm Society regarding the safety of same-day discharge following intracardiac catheter ablation.

A study was conducted to determine the clinical efficacy of GLP-1RAs for secondary prevention of atrial fibrillation and ...

Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including SGLT2is and GLP-1 RAs.